|
ARRDC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.205700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.855700E-02 |
| Normal-vs-Stage2 |
3.508300E-02 |
| Normal-vs-Stage3 |
2.622300E-02 |
| Normal-vs-Stage4 |
1.402170E-02 |
| Stage1-vs-Stage2 |
3.463600E-01 |
| Stage1-vs-Stage3 |
3.596000E-01 |
| Stage1-vs-Stage4 |
1.710220E-01 |
| Stage2-vs-Stage3 |
7.291200E-01 |
| Stage2-vs-Stage4 |
8.916600E-01 |
| Stage3-vs-Stage4 |
5.746200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.391600E-02 |
| Normal-vs-AfricanAmerican |
8.884400E-01 |
| Normal-vs-Asian |
1.962440E-02 |
| Caucasian-vs-AfricanAmerican |
2.382200E-02 |
| Caucasian-vs-Asian |
3.738600E-01 |
| AfricanAmerican-vs-Asian |
1.652360E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.066100E-02 |
| Normal-vs-Female |
3.935600E-02 |
| Male-vs-Female |
6.449000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.421410E-01 |
| Normal-vs-Age(41-60Yrs) |
2.921900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.937600E-03 |
| Normal-vs-Age(81-100Yrs) |
3.381600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.392010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.099940E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.371200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.152600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.661800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.843400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.842300E-03 |
| Classical-VS-Follicular |
1.281690E-02 |
| Classical-VS-Other |
1.522250E-01 |
| Classical-VS-Normal |
1.425570E-01 |
| Tall-VS-Follicular |
7.007000E-01 |
| Tall-VS-Other |
5.717200E-01 |
| Tall-VS-Normal |
3.342300E-03 |
| Follicular-VS-Other |
6.094800E-01 |
| Follicular-VS-Normal |
5.081200E-03 |
| Other-VS-Normal |
1.131230E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.148330E-02 |
| Normal-vs-N1 |
7.499900E-02 |
| N0-vs-N1 |
4.620400E-01 |
|
|
